Abstract
Cardiobacterium valvarum is a relatively novel agent of infective endocarditis. We describe the first case of infective endocarditis due to this pathogen in the Asian Pacific. This case is unique in its involvement of the mitral valve as well as its clinical resolution exclusively resulting from treatment with antibiotics without resorting to valve replacement/explantation.
MeSH terms
-
Anti-Bacterial Agents / therapeutic use
-
Cardiobacterium / isolation & purification*
-
DNA, Bacterial / chemistry
-
DNA, Bacterial / genetics
-
DNA, Ribosomal / chemistry
-
DNA, Ribosomal / genetics
-
Endocarditis, Bacterial / diagnosis*
-
Endocarditis, Bacterial / drug therapy
-
Endocarditis, Bacterial / microbiology
-
Endocarditis, Bacterial / pathology
-
Female
-
Gram-Negative Bacterial Infections / diagnosis*
-
Gram-Negative Bacterial Infections / drug therapy
-
Gram-Negative Bacterial Infections / microbiology
-
Gram-Negative Bacterial Infections / pathology
-
Heart Septal Defects, Ventricular / complications*
-
Humans
-
Middle Aged
-
Mitral Valve / pathology*
-
RNA, Ribosomal, 16S / genetics
-
Sequence Analysis, DNA
-
Singapore
-
Treatment Outcome
Substances
-
Anti-Bacterial Agents
-
DNA, Bacterial
-
DNA, Ribosomal
-
RNA, Ribosomal, 16S